Sandy Allerheiligen
Senior Vice President, Strategic Consulting
Certara
Canada
Biography
Sandy Allerheiligen, PhD joined Certara in 2017 and was named Senior Vice President of Strategic Consulting, Health Economics, and Education. Her recent work has focused on using her predictive, economic, and model-informed drug development expertise to quantify a drug’s value to patients and justify its cost to payers. Prior to joining Certara, she held positions at Merck (Vice President of Modeling and Simulation, Vice President of Quantitative Pharmacology and Pharmacometrics, and Vice President of Predictive and Economic Modeling). In addition to Merck, Dr. Allerheiligen worked at Lilly for 20 years in PKPD and retired as Distinguished Fellow and Chief Scientific Officer of Quantitative Pharmacology.
Research Interest
drug developement
